7KWW image
Entry Detail
PDB ID:
7KWW
Title:
X-ray Crystal Structure of PlyCB Mutant K59H
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-12-02
Release Date:
2021-04-07
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.19
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
I 4 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PlyCB
Mutations:K59H
Chain IDs:A, B
Chain Length:72
Number of Molecules:2
Biological Source:Streptococcus virus C1
Ligand Molecules
Primary Citation
High avidity drives the interaction between the streptococcal C1 phage endolysin, PlyC, with the cell surface carbohydrates of Group A Streptococcus.
Mol.Microbiol. 116 397 415 (2021)
PMID: 33756056 DOI: 10.1111/mmi.14719

Abstact

Endolysin enzymes from bacteriophage cause bacterial lysis by degrading the peptidoglycan cell wall. The streptococcal C1 phage endolysin PlyC, is the most potent endolysin described to date and can rapidly lyse group A, C, and E streptococci. PlyC is known to bind the Group A streptococcal cell wall, but the specific molecular target or the binding site within PlyC remain uncharacterized. Here we report for the first time, that the polyrhamnose backbone of the Group A streptococcal cell wall is the binding target of PlyC. We have also characterized the putative rhamnose binding groove of PlyC and found four key residues that were critical to either the folding or the cell wall binding action of PlyC. Based on our results, we suggest that the interaction between PlyC and the cell wall may not be a high-affinity interaction as previously proposed, but rather a high avidity one, allowing for PlyC's remarkable lytic activity. Resistance to our current antibiotics is reaching crisis levels and there is an urgent need to develop the antibacterial agents with new modes of action. A detailed understanding of this potent endolysin may facilitate future developments of PlyC as a tool against the rise of antibiotic resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures